Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term survival, toxicities, and the role of chrono-chemotherapy with different infusion rates in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy: a retrospective study with a 5-year follow-up.
Liu L, Luo X, Wu W, Li Y, Long J, Luo X, Chen X, Gong X, Zhao C, He Q, Li Z, Shang K, Chen Y, Xinyu X, Jin F. Liu L, et al. Among authors: luo x. Front Oncol. 2024 Mar 22;14:1371878. doi: 10.3389/fonc.2024.1371878. eCollection 2024. Front Oncol. 2024. PMID: 38585011 Free PMC article.
Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial.
Shang K, Li T, Chen Y, Luo X, Wu H, Zhou Y, Song J, Wu W, Li Y, Luo X, Chen X, Gong X, Zhao C, Li Z, Liu L, He Q, Long J, Jin F. Shang K, et al. Among authors: luo x. Oral Oncol. 2024 Dec;159:107087. doi: 10.1016/j.oraloncology.2024.107087. Epub 2024 Nov 3. Oral Oncol. 2024. PMID: 39488901 Free article. Clinical Trial.
Ultrasound-activated erythrocyte membrane-camouflaged Pt (II) layered double hydroxide enhances PD-1 inhibitor efficacy in triple-negative breast cancer through cGAS-STING pathway-mediated immunogenic cell death.
Wu Y, Zhao Z, Ma M, Zhang W, Liu W, Liang X, Zhao T, Luo Y, Wang Y, Li M, Li T, Liu C, Luo X, Wang S, Li W, Zeng W, Wang H, Li W, Wu T, Ke Z, Luo F. Wu Y, et al. Among authors: luo x. Theranostics. 2025 Jan 2;15(4):1456-1477. doi: 10.7150/thno.102284. eCollection 2025. Theranostics. 2025. PMID: 39816689 Free PMC article.
20,215 results
You have reached the last available page of results. Please see the User Guide for more information.